Patrick H.C. van Berkel

3.2k total citations
27 papers, 2.5k citations indexed

About

Patrick H.C. van Berkel is a scholar working on Molecular Biology, Nutrition and Dietetics and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Patrick H.C. van Berkel has authored 27 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 14 papers in Nutrition and Dietetics and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Patrick H.C. van Berkel's work include Infant Nutrition and Health (14 papers), Glycosylation and Glycoproteins Research (10 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Patrick H.C. van Berkel is often cited by papers focused on Infant Nutrition and Health (14 papers), Glycosylation and Glycoproteins Research (10 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Patrick H.C. van Berkel collaborates with scholars based in Netherlands, United States and Germany. Patrick H.C. van Berkel's co-authors include Jan H. Nuijens, Marlieke Geerts, Paul W.H.I. Parren, Jan G. J. van de Winkel, Harrie A. van Veen, F.L. Schanbacher, Mick M. Welling, Peter H. Nibbering, Frank Pieper and Ewald T.J. van den Bremer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Patrick H.C. van Berkel

27 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick H.C. van Berkel Netherlands	22	1.2k	913	800	460	370	27	2.5k
J P Vaerman Belgium	26	642 0.5×	194 0.2×	519 0.6×	706 1.5×	193 0.5×	71	2.4k
Jean‐Luc Desseyn France	27	1.2k 1.0×	210 0.2×	183 0.2×	386 0.8×	185 0.5×	57	2.0k
Neil W. Toribara United States	22	2.0k 1.7×	187 0.2×	429 0.5×	795 1.7×	660 1.8×	32	3.2k
Michael E. Breimer Sweden	36	2.0k 1.6×	211 0.2×	383 0.5×	572 1.2×	136 0.4×	136	4.1k
Marlieke Geerts Netherlands	13	460 0.4×	613 0.7×	115 0.1×	369 0.8×	51 0.1×	17	1.3k
Richard L. Friedman United States	20	854 0.7×	170 0.2×	114 0.1×	792 1.7×	490 1.3×	35	3.3k
David Snary United Kingdom	33	1.3k 1.1×	139 0.2×	509 0.6×	1.1k 2.5×	315 0.9×	77	3.1k
Yi Lasanajak United States	28	1.6k 1.3×	303 0.3×	292 0.4×	474 1.0×	118 0.3×	66	2.6k
Jean‐Paul Prieels Belgium	19	895 0.7×	213 0.2×	160 0.2×	381 0.8×	69 0.2×	34	2.0k
Majlis Svensson Sweden	25	741 0.6×	216 0.2×	85 0.1×	551 1.2×	91 0.2×	51	2.1k

Countries citing papers authored by Patrick H.C. van Berkel

Since Specialization

Citations

This map shows the geographic impact of Patrick H.C. van Berkel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick H.C. van Berkel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick H.C. van Berkel more than expected).

Fields of papers citing papers by Patrick H.C. van Berkel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick H.C. van Berkel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick H.C. van Berkel. The network helps show where Patrick H.C. van Berkel may publish in the future.

Co-authorship network of co-authors of Patrick H.C. van Berkel

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick H.C. van Berkel. A scholar is included among the top collaborators of Patrick H.C. van Berkel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick H.C. van Berkel. Patrick H.C. van Berkel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Goeij, Bart E.C.G. de, David Satijn, Richard Wubbolts, et al.. (2015). High Turnover of Tissue Factor Enables Efficient Intracellular Delivery of Antibody–Drug Conjugates. Molecular Cancer Therapeutics. 14(5). 1130–1140. 78 indexed citations

Rose, Rebecca, Patrick H.C. van Berkel, Ewald T.J. van den Bremer, et al.. (2013). Mutation of Y407 in the CH3 domain dramatically alters glycosylation and structure of human IgG. mAbs. 5(2). 219–228. 53 indexed citations

Kalay, Hakan, Martino Ambrosini, Patrick H.C. van Berkel, et al.. (2012). Online nanoliquid chromatography–mass spectrometry and nanofluorescence detection for high-resolution quantitative N-glycan analysis. Analytical Biochemistry. 423(1). 153–162. 31 indexed citations

Repp, Roland, Christian Kellner, Dalia Akramienė, et al.. (2011). Combined Fc-protein- and Fc-glyco-engineering of scFv-Fc fusion proteins synergistically enhances CD16a binding but does not further enhance NK-cell mediated ADCC. Journal of Immunological Methods. 373(1-2). 67–78. 38 indexed citations

Rose, Rebecca, Aran F. Labrijn, Ewald T.J. van den Bremer, et al.. (2011). Quantitative Analysis of the Interaction Strength and Dynamics of Human IgG4 Half Molecules by Native Mass Spectrometry. Structure. 19(9). 1274–1282. 72 indexed citations

Gramer, Michael J., et al.. (2011). Modulation of antibody galactosylation through feeding of uridine, manganese chloride, and galactose. Biotechnology and Bioengineering. 108(7). 1591–1602. 140 indexed citations

Schneider‐Merck, Tanja, Jeroen J. Lammerts van Bueren, Sven Berger, et al.. (2009). Human IgG2 Antibodies against Epidermal Growth Factor Receptor Effectively Trigger Antibody-Dependent Cellular Cytotoxicity but, in Contrast to IgG1, Only by Cells of Myeloid Lineage. The Journal of Immunology. 184(1). 512–520. 167 indexed citations

Berkel, Patrick H.C. van, et al.. (2009). Rapid production of recombinant human IgG With improved ADCC effector function in a transient expression system. Biotechnology and Bioengineering. 105(2). 350–357. 33 indexed citations

Berkel, Patrick H.C. van, et al.. (2009). N‐linked glycosylation is an important parameter for optimal selection of cell lines producing biopharmaceutical human IgG. Biotechnology Progress. 25(1). 244–251. 62 indexed citations

10.

Veen, Harrie A. van, et al.. (2006). Characterization of Bovine Neutrophil Gelatinase-Associated Lipocalin. Journal of Dairy Science. 89(9). 3400–3407. 10 indexed citations

11.

Thomassen, Ellen A. J., Harrie A. van Veen, Patrick H.C. van Berkel, Jan H. Nuijens, & Jan Pieter Abrahams. (2005). The protein structure of recombinant human lactoferrin produced in the milk of transgenic cows closely matches the structure of human milk-derived lactoferrin. Transgenic Research. 14(4). 397–405. 37 indexed citations

12.

Veen, Harrie A. van, Marlieke Geerts, Patrick H.C. van Berkel, & Jan H. Nuijens. (2004). The role of N‐linked glycosylation in the protection of human and bovine lactoferrin against tryptic proteolysis. European Journal of Biochemistry. 271(4). 678–684. 105 indexed citations

13.

Guillén, C., Iain B. McInnes, D. Vaughan, et al.. (2002). Enhanced Th1 Response to Staphylococcus aureus Infection in Human Lactoferrin-Transgenic Mice. The Journal of Immunology. 168(8). 3950–3957. 77 indexed citations

14.

Veen, Harrie A. van, Marlieke Geerts, Patrick H.C. van Berkel, & Jan H. Nuijens. (2002). Analytical cation-exchange chromatography to assess the identity, purity, and N-terminal integrity of human lactoferrin. Analytical Biochemistry. 309(1). 60–66. 18 indexed citations

15.

Berkel, Patrick H.C. van, Harrie A. van Veen, Marlieke Geerts, & Jan H. Nuijens. (2002). Characterization of monoclonal antibodies against human lactoferrin. Journal of Immunological Methods. 267(2). 139–150. 9 indexed citations

16.

Berkel, Patrick H.C. van, Mick M. Welling, Marlieke Geerts, et al.. (2002). Large scale production of recombinant human lactoferrin in the milk of transgenic cows. Nature Biotechnology. 20(5). 484–487. 213 indexed citations

17.

Legrand, Dominique, Patrick H.C. van Berkel, Valérie Salmon, et al.. (1998). Role of the First N-Terminal Basic Cluster of Human Lactoferrin (R2R3R4R5) in the Interactions with the Jurkat Human Lymphoblastic T-Cells. Advances in experimental medicine and biology. 443. 49–55. 7 indexed citations

18.

Nuijens, Jan H., et al.. (1997). Characterization of Recombinant Human Lactoferrin Secreted in Milk of Transgenic Mice. Journal of Biological Chemistry. 272(13). 8802–8807. 61 indexed citations

19.

Nuijens, Jan H., Patrick H.C. van Berkel, & F.L. Schanbacher. (1996). Structure and biological actions of lactoferrin. Journal of Mammary Gland Biology and Neoplasia. 1(3). 285–295. 172 indexed citations

20.

Neck, Johan W. van, Patrick H.C. van Berkel, Pieter Telleman, et al.. (1992). Effect of ploidy on transcription levels in cultured rat aortic smooth muscle cells. FEBS Letters. 297(1-2). 189–195. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact